142 related articles for article (PubMed ID: 29441946)
21. Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
Kang S; Lee JM; Jeon B; Elkamhawy A; Paik S; Hong J; Oh SJ; Paek SH; Lee CJ; Hassan AHE; Kang SS; Roh EJ
Eur J Med Chem; 2018 May; 151():186-198. PubMed ID: 29614416
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial potentiality of a phenothiazine group of antipsychotic drug-prochlorperazine.
Mazumder R; Chaudhuri SR; Mazumder A
Indian J Exp Biol; 2002 Jul; 40(7):828-30. PubMed ID: 12597553
[TBL] [Abstract][Full Text] [Related]
23. MSH activity in pituitary glands of rats treated with tranquilizing drugs.
Kastin AJ; Schally AV
Endocrinology; 1966 Nov; 79(5):1018-20. PubMed ID: 5951274
[No Abstract] [Full Text] [Related]
24. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115
[TBL] [Abstract][Full Text] [Related]
25. Heat processing effect of luteolin on anti-metastasis activity of human glioblastoma cells U87.
El Gueder D; Maatouk M; Kalboussi Z; Daouefi Z; Chaaban H; Ioannou I; Ghedira K; Ghedira LC; Luis J
Environ Sci Pollut Res Int; 2018 Dec; 25(36):36545-36554. PubMed ID: 30374718
[TBL] [Abstract][Full Text] [Related]
26. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.
Cheng HW; Liang YH; Kuo YL; Chuu CP; Lin CY; Lee MH; Wu AT; Yeh CT; Chen EI; Whang-Peng J; Su CL; Huang CY
Cell Death Dis; 2015 May; 6(5):e1753. PubMed ID: 25950483
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.
Krishan A; Sridhar KS; Mou C; Stein WD; Lyubimov E; Hu YP; Fernandez H
Clin Cancer Res; 2000 Apr; 6(4):1508-17. PubMed ID: 10778983
[TBL] [Abstract][Full Text] [Related]
28. ECG-changes induced by phenothiazine drugs in the anaesthetized rat.
Langslet A
Acta Pharmacol Toxicol (Copenh); 1970; 28(4):258-64. PubMed ID: 5536015
[No Abstract] [Full Text] [Related]
29. Blockade of HERG human K+ channel and IKr of guinea pig cardiomyocytes by prochlorperazine.
Kim MD; Eun SY; Jo SH
Eur J Pharmacol; 2006 Aug; 544(1-3):82-90. PubMed ID: 16860311
[TBL] [Abstract][Full Text] [Related]
30. Perphenazine-Associated Nausea: A Case of Protracted Withdrawal.
Singh N; Sood N; Jolly T
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):606-608. PubMed ID: 34369907
[No Abstract] [Full Text] [Related]
31. Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
Ranjan A; Srivastava SK
Oncotarget; 2017 May; 8(20):32960-32976. PubMed ID: 28380428
[TBL] [Abstract][Full Text] [Related]
32. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
33. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
34. No effects of quaternary neuroleptics on human prolactin and adenylcyclase.
Langer G; Ahn HS; Perel JM; Makman MH; Sachar EJ
Lancet; 1977 Feb; 1(8009):493. PubMed ID: 65604
[No Abstract] [Full Text] [Related]
35. Adding perphenazine to increase effectiveness of standard glioblastoma chemoirradiation.
Kast RE
J BUON; 2020; 25(4):1676-1686. PubMed ID: 33099901
[TBL] [Abstract][Full Text] [Related]
36. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
[TBL] [Abstract][Full Text] [Related]
37. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
38. Exploring anticancer activity of structurally modified benzylphenoxyacetamide (BPA); I: Synthesis strategies and computational analyses of substituted BPA variants with high anti-glioblastoma potential.
Stalinska J; Houser L; Rak M; Colley SB; Reiss K; Jursic BS
Sci Rep; 2019 Nov; 9(1):17021. PubMed ID: 31745126
[TBL] [Abstract][Full Text] [Related]
39. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
40. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
